During this segment, David Calabrese, RPh, MHP, and Kenneth L. Schaecher, MD, FACP, CPC, discuss accountable care organizations (ACOs) and their impact on patient care.
Dr Schaecher explains that although ACOs are constructed to benefit healthcare professionals and patients, he fears that an ACO model of care may cause clinicians to under-utilize expensive drug
therapies.
Dr Schaecher hopes that healthcare professionals will continue to make the best choice for their patients and ignore the financial pressures that often play a role in the treatment decision-making process.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
RFK Jr Claims HHS Has Not Fired Working Scientists, Canceled Lifesaving Research
May 15th 2025Robert F. Kennedy Jr’s congressional hearing featured numerous statements from the secretary of HHS, including denouncing claims of cutting down the HHS and the National Institutes of Health.
Read More
Trump Administration Walks Back Mental Health Parity in Insurance Coverage
May 13th 2025The Trump administration has decided to further debate the federal rule passed during the Biden administration that guaranteed insurance coverage for treatment of mental illness and substance abuse.
Read More